Almeida R

Centre for Advanced Medical Psychedelics (CAMP), Natal, Rio Grande do Norte, Brazil; Department of Physiology and Behaviour, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.

7 papers · 2 preprints · ORCID

ArticleDMT

Corrigendum to Safety, tolerability and subjective effects of vaporized N, N-Dimethyltryptamine: A randomized double-blind clinical trial [European Neuropsychopharmacology 97 (2025) 16-27].

Wießner I, Falchi-Carvalho M, Laborde S +18

Europe PMC2026
ArticleMDMA

Lifetime MDMA use and associations with meaning in life in the context of childhood trauma.

Olofsson M, Acar K, Simonsson O +5

Europe PMC2026
ArticleDMT

Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial.

Wießner I, Falchi-Carvalho M, Laborde S +18

Europe PMC2025
ArticlePsilocybin

Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.

Falchi-Carvalho M, Palhano-Fontes F, Wießner I +21

Europe PMC2025
ArticleAyahuasca

The Antidepressant Effects of Vaporized <i>N</i>,<i>N</i>-Dimethyltryptamine: An Open-Label Pilot Trial in Treatment-Resistant Depression.

Falchi-Carvalho M, Barros H, Bolcont R +16

Europe PMC2025
PreprintAyahuasca

The antidepressant effects of vaporized N,N-Dimethyltryptamine: a preliminary report in treatment-resistant depression

Falchi-Carvalho M, Barros H, Bolcont R +15

Europe PMC2024
PreprintDMT

Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice

Nogueira M, Golbert DF, Menezes R +7

Europe PMC2023
ArticlePsilocybin

Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.

Falchi-Carvalho M, Wießner I, Silva SRB +15

Europe PMC2024
ArticlePsychedelics

Psychedelic drug use and schizotypy in young adults.

Lebedev AV, Acar K, Garzón B +11

Europe PMC2021